Skip to content

The effect of Coriander seed on gastro-esophageal reflux disease

The effect of Coriander seed capsule on gastro-esophageal reflux disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230611058455N1
Enrollment
110
Registered
2023-06-24
Start date
2023-08-06
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux. Gastro-esophageal reflux disease

Interventions

Intervention 1: Intervention group: All patients will take the same drugs prescribed by the internal specialist, and in addition, the intervention group will take coriander seed capsules (500 mg capsu

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18 to 60 Outpatients with history of at least 4 weeks of major reflux symptoms in the last 3 months Informed consent to participating in the study Consent to avoiding out of protocol medication

Exclusion criteria

Exclusion criteria: History of gastrointestinal cancers in the patient and first degree relatives History of esophageal, abdominal or stomach surgery Suffering from diabetes, acute peptic ulcer, achalasia and acute gastrointestinal diseases, gastrointestinal bleeding, iron deficiency anemia, anorexia, persistent vomiting, unexplained weight loss, pregnancy Taking aspirin and warfarin/taking herbal medicines one month before the study Impotency and sperm production disorders/severe amnesia Presence of dysphagia and odynophagia History of obstructive diseases(kidney and gallbladder stone)\amenorrhea or oligomenorrhea

Design outcomes

Primary

MeasureTime frame
Symptoms of gastro-esophageal reflux disease. Timepoint: At the beginning of the stydy, the end of the third week and the end of the sixth week. Method of measurement: Frequency Scale for the Symptoms of GERD (FSSG)Questionnaire.

Secondary

MeasureTime frame
Evaluation of quality of life in reflux and dyspepsia. Timepoint: At the beginning of the study,the end of the third week and the end of the sixth week. Method of measurement: Quality of Life in Reflux and Dyspepsia(QOLRAD)Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Shamsian

Ghoum University of Medical Sciences

f.shamsian@muq.ac.ir+98 25 3776 4074

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026